Eurand to Present at Bank of America Merrill Lynch Health Care Conference
April 27 2010 - 8:00AM
Marketwired
Eurand N.V. (NASDAQ: EURX), a global specialty pharmaceutical
company, announced today that John Fraher, Chief Commercial
Officer, is scheduled to present at the Bank of America Merrill
Lynch Health Care Conference. Details are as follows:
Date: Tuesday, May 11, 2010
Time: 9:20 a.m. ET
Place: Grand Hyatt Hotel
109 East 42nd Street at Grand Central Terminal
New York, N.Y.
A live audio webcast of the presentation can be accessed in the
investor relations section of Eurand's web site at www.eurand.com
and will be available via replay for 30 days.
About Eurand
Eurand is a specialty pharmaceutical company that develops,
manufactures and commercializes enhanced pharmaceutical and
biopharmaceutical products based on its proprietary pharmaceutical
technologies. Eurand has had six products approved by the FDA since
2001 and has a pipeline of product candidates in development for
itself and its collaboration partners. Its technology platforms
include bioavailability enhancement of poorly soluble drugs, custom
release profiles and taste-masking orally disintegrating tablet
(ODT) formulations. Eurand is a global company with facilities in
the U.S. and Europe. For more information, visit
www.eurand.com.
Contacts: Bill Newbould Vice President, Investor Relations
Eurand N.V. +1 267-759-9335 Email Contact Nick Laudico/Sara
Pellegrino The Ruth Group +1 646-536-7030/7002 Email Contact Email
Contact
Eurand N.V. (MM) (NASDAQ:EURX)
Historical Stock Chart
From Jul 2024 to Aug 2024
Eurand N.V. (MM) (NASDAQ:EURX)
Historical Stock Chart
From Aug 2023 to Aug 2024